Insights Into Vertex Pharmaceuticals, Inc. (VRTX) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Vertex Pharmaceuticals, Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $433.87 and fluctuated between $435.19 as its day high and $431.00 as its day low. The current market capitalization of Vertex Pharmaceuticals, Inc. is $111.80B. A total of 1.42 million shares were traded on the day, compared to an average of 1.53M shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, VRTX has seen 1 BUY and 5 SELL insider trades, representing the acquisition of 11,250 and the disposition of 22,051 shares. Over the last 12 months, there were 12 BUYs and 194 SELLs from insiders. Insiders purchased 70,095 shares during that period but sold 400,587.

In the most recent transaction, LEIDEN JEFFREY M sold 6,648 shares of VRTX for 419.07 per share on Jan 08. After the transaction, the Executive Chairman now owns 2,423 company shares. In a previous transaction on Jan 02, WAGNER CHARLES F JR sold 3,000 shares at 405.00 per share. VRTX shares that EVP & Chief Financial Officer owns now total 43,693.

Among the insiders who sold shares, Kewalramani Reshma disposed of 17,135 shares on Dec 15 at a per-share price of $407.00. This resulted in the CEO & President holding 108,711 shares of VRTX after the transaction. In another insider transaction, LEIDEN JEFFREY M sold 13,354 shares at $399.42 per share on Dec 13. Company shares held by the Executive Chairman now total 9,071.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for VRTX in the last 3 months, the mean price target is $443.04 with high estimates of $559.00 and low estimates of $325.00. In terms of 52-week highs and lows, VRTX has a high of $448.40 and a low of $283.60.

As of this writing, VRTX has an earnings estimate of $4.11 per share for the current quarter. EPS was calculated based on a consensus of 20 estimates, with a high estimate of $4.43 per share and a lower estimate of $3.83. The company reported an EPS of $3.89 in the last quarter, which was 0.30% higher than expectations of $3.88.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $64.05, while its Total Shareholder’s Equity was $10.10B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.31.

Most Popular

Related Posts